Cadrenal Therapeutics (CVKD) vs GeoVax Labs (GOVX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($3.2 million vs $2.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVKD | GOVX |
|---|---|---|
| Share price | $0.9101 | $0.281 |
| Market cap | $3.25M | $2.84M |
| 1-day change | -2.10% | -1.95% |
| EPS (TTM) | $-4.91 | $-8.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $15.75 |
| 52-week low | $0.85 | $0.2705 |
| Distance from 52-week high | -93.72% | -98.22% |
| Analyst consensus | none | none |
| Avg. price target upside | +1438.29% | +3458.72% |
| Average volume | 458.82K | 771.47K |
| Shares outstanding | 3.57M | 10.10M |
| Employees | 5 | 19 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About GeoVax Labs
GOVX stock →GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine.
Health Care · Biotechnology: Pharmaceutical Preparations · 19 employees
CVKD vs GOVX FAQ
Which is bigger, Cadrenal Therapeutics or GeoVax Labs?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $3.25M compared with $2.84M for GeoVax Labs (GOVX).
Are Cadrenal Therapeutics and GeoVax Labs in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.